155 related articles for article (PubMed ID: 1653073)
1. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.
Renesto P; Balloy V; Vargaftig BB; Chignard M
Br J Pharmacol; 1991 Jun; 103(2):1435-40. PubMed ID: 1653073
[TBL] [Abstract][Full Text] [Related]
2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
Renesto P; Chignard M
J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
[TBL] [Abstract][Full Text] [Related]
4. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
[TBL] [Abstract][Full Text] [Related]
5. Effect of azelastine hydrochloride on release and production of platelet activating factor in human neutrophils.
Shindo K; Fukumura M; Hirai Y; Koide K
Prostaglandins Leukot Essent Fatty Acids; 1997 May; 56(5):373-7. PubMed ID: 9175174
[TBL] [Abstract][Full Text] [Related]
6. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
Maugeri N; Evangelista V; Piccardoni P; Dell'Elba G; Celardo A; de Gaetano G; Cerletti C
Blood; 1992 Jul; 80(2):447-51. PubMed ID: 1627802
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
Renesto P; Chignard M
Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1993 Aug; 17(4):417-25. PubMed ID: 8406686
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
[TBL] [Abstract][Full Text] [Related]
11. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.
Coëffier E; Joseph D; Prévost MC; Vargaftig BB
Br J Pharmacol; 1987 Oct; 92(2):393-406. PubMed ID: 3118996
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
Maugeri N; Evangelista V; Celardo A; Dell'Elba G; Martelli N; Piccardoni P; de Gaetano G; Cerletti C
Thromb Haemost; 1994 Sep; 72(3):450-6. PubMed ID: 7531878
[TBL] [Abstract][Full Text] [Related]
13. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
[TBL] [Abstract][Full Text] [Related]
14. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
Brom C; Brom J; König W
Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
[TBL] [Abstract][Full Text] [Related]
15. Azelastine hydrochloride inhibits platelet activating factor-like activity in human eosinophils.
Shindo K; Fukumura M
Prostaglandins Leukot Essent Fatty Acids; 1996 Oct; 55(4):217-21. PubMed ID: 8951989
[TBL] [Abstract][Full Text] [Related]
16. Modulation by superoxide anions of neutrophil-mediated platelet activation.
Renesto P; Si Tahar M; Chignard M
Biochem Pharmacol; 1994 Apr; 47(8):1401-4. PubMed ID: 8185647
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
18. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
Renesto P; Chignard M
J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
Faint RW; Mackie IJ; Machin SJ
Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
[TBL] [Abstract][Full Text] [Related]
20. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
